Trading Alert : Warren Resources

Volume and price moving higher on this undervalued play

 

WARREN RESOURCES INC(WRES:NASDAQ, US)

BuySell
5.20USDIncrease0.39(8.11%)Volume: 
Above Average
As of 17 Apr 2014 at 10:36 AM EDT.  

QUOTE DETAILS

Open 4.81 P/E Ratio (TTM) 11.5x
Last Bid/Size 5.20 / 2 EPS (TTM) 0.42
Last Ask/Size 5.21 / 10 Next Earnings 5 May 2014
Previous Close 4.81 Beta 2.32
Volume 876,420 Last Dividend
Average Volume 592,419 Dividend Yield 0.00%
Day High 5.25 Ex-Dividend Date
Day Low 4.81 Shares Outstanding 73.1M
52 Week High 5.27 # of Floating Shares 69.65162M
52 Week Low 2.46 Short Interest as % of Float 2.00%

Trading Alert: TINY Rises above the DOW slide

HARRIS AND HARRIS GROUP INC(TINY:NASDAQ, US)

 

PRICE up – volume nothing special

BuySell
Jack A. Bass Managed Accounts added today at $ 3.66
3.73USDIncrease0.16(4.48%)Volume: 
Below Average
As of 07 Apr 2014 at 3:56 PM EDT.

 

QUOTE DETAILS

Open 3.59 P/E Ratio (TTM)
Last Bid/Size 3.71 / 6 EPS (TTM) -0.65
Last Ask/Size 3.73 / 11 Next Earnings 5 May 2014
Previous Close 3.57 Beta 1.33
Volume 142,505 Last Dividend
Average Volume 164,877 Dividend Yield 0.00%
Day High 3.73 Ex-Dividend Date
Day Low 3.51 Shares Outstanding 31.2M
52 Week High 3.94 # of Floating Shares 28.56703M
52 Week Low 2.83 Short Interest as % of Float 0.66%

Trading Alert Castle Brand Inc. ( ROX)

Down turn this morning now being reversed with huge volume increases.

Until a few minutes ago the stock was off 7 to 8 cents on volume of 507,000

It appears someone with funds is moving in.

CASTLE BRANDS INC(ROX:NYSE MKT LLC, US)

BuySell
1.29USDDecrease0.025(-1.91%)Volume: 
Average
As of 04 Apr 2014 at 3:19 PM EDT.

QUOTE DETAILS

Open 1.30 P/E Ratio (TTM)
Last Bid/Size 1.28 / 101 EPS (TTM) -0.11
Last Ask/Size 1.29 / 39 Next Earnings
Previous Close 1.31 Beta 0.88
Volume 935,062 Last Dividend
Average Volume 1,162,065 Dividend Yield 0.00%
Day High 1.31 Ex-Dividend Date
Day Low 1.23 Shares Outstanding 150.1M
52 Week High 1.55 # of Floating Shares 64.09849M
52 Week Low 0.2652 Short Interest as % of Float 0.48%

 

A TINY Trading Alert :

TINY is volatile as few shares trade . watch the few shares available at Level 2

HARRIS AND HARRIS GROUP INC(TINY:NASDAQ, US)

Buy
3.64USDIncrease0.09(2.54%)Volume: 
Below Average
As of 02 Apr 2014 at 10:37 AM EDT.

 

QUOTE DETAILS

Open 3.53 P/E Ratio (TTM)
Last Bid/Size 3.62 / 49 EPS (TTM) -0.65
Last Ask/Size 3.64 / 29 Next Earnings 5 May 2014
Previous Close 3.55 Beta 1.33
Volume 21,395 Last Dividend
Average Volume 183,394 Dividend Yield 0.00%
Day High 3.64 Ex-Dividend Date
Day Low 3.50 Shares Outstanding 31.2M
52 Week High 3.94 # of Floating Shares 28.52751M
52 Week Low 2.83 Short Interest as % of Float 0.66%
chart

LEVEL 2 QUOTE

È

Market Maker Shares Bid Price Ask Price Shares Market Maker
Direct Edge ECN LLC 4,900 3.620 3.640 100 Archipelago Stock Exchange
UBS Securities LLC 700 3.610 3.640 200
100 3.600 3.640 200 Nasdaq Execution Services, LLC.
Nasdaq Execution Services, LLC. 100 3.600 3.640 100 Philadelphia Stock Exchange
Bats Trading, Inc. 100 3.580 3.640 100 Timber Hill LLC
Archipelago Stock Exchange 100 3.570 3.640 2,600 UBS Securities LLC
Citigroup Global Markets Inc. 100 3.550 3.670 Bats Trading, Inc.
Direct Edge ECN LLC 100 3.500 3.700 100

Trading Alert : Castle Brands – Price and Volume

Volume in the first hour equal to one full  day recent ( reduced volume)

 

CASTLE BRANDS INC(ROX:NYSE MKT LLC, US)

Buy
1.26USDIncrease0.05(4.13%)Volume: 
Above Average
As of 02 Apr 2014 at 10:28 AM EDT.

QUOTE DETAILS

Open 1.21 P/E Ratio (TTM)
Last Bid/Size 1.25 / 3 EPS (TTM) -0.11
Last Ask/Size 1.26 / 37 Next Earnings
Previous Close 1.21 Beta 0.88
Volume 520,242 Last Dividend
Average Volume 574,184 Dividend Yield 0.00%
Day High 1.29 Ex-Dividend Date
Day Low 1.18 Shares Outstanding 150.1M
52 Week High 1.55 # of Floating Shares 64.09849M
52 Week Low 0.2652 Short Interest as % of Float 0.48%

 

Trading Alert : Castle Brands Moving Up

After a very dull opening this day and last the volume of shares traded and the share price has lifted.

Up until 30 minutes ago the volume was only 157,000 and in the last one-half hour more than 350,00 shares have traded.

Jack A. Bass Managed Accounts hold shares in ROX

CASTLE BRANDS INC(ROX:NYSE MKT LLC, US)

BuySell
1.27USDIncrease0.06(4.96%)Volume: 
Above Average
As of 25 Mar 2014 at 2:17 PM EDT.

 

QUOTE DETAILS
Open 1.23 P/E Ratio (TTM)
Last Bid/Size 1.26 / 98 EPS (TTM) -0.11
Last Ask/Size 1.27 / 330 Next Earnings
Previous Close 1.21 Beta 0.86
Volume 554,795 Last Dividend
Average Volume 700,955 Dividend Yield 0.00%
Day High 1.28 Ex-Dividend Date
Day Low 1.18 Shares Outstanding 150.1M
52 Week High 1.55 # of Floating Shares 64.09849M
52 Week Low 0.2652 Short Interest as % of Float 0.56%

OPKO Health News Release – helps stem drift

American Urological Association (AUA) Accepts 4Kscore Test Clinical Study for Plenary Presentation at 2014 Annual Meeting

Jack A. Bass Managed accounts holds OPK

OPKO HEALTH INC(OPK:NYSE, US)

BuySell
9.27USDDecrease0.02(-0.22%)Volume: 
Below Average
As of 25 Mar 2014 at 12:50 PM EDT.

 

QUOTE DETAILS
Open 9.41 P/E Ratio (TTM)
Last Bid/Size 9.27 / 14 EPS (TTM) -0.33
Last Ask/Size 9.28 / 2 Next Earnings 5 May 2014
Previous Close 9.29 Beta 1.06
Volume 1,263,992 Last Dividend
Average Volume 2,971,264 Dividend Yield 0.00%
Day High 9.50 Ex-Dividend Date
Day Low 9.07 Shares Outstanding 412.9M
52 Week High 12.95 # of Floating Shares 221.0759M
52 Week Low 6.14 Short Interest as % of Float 20.64%

 

MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) today announced that the American Urological Association (AUA) has accepted “The 4KscoreTM Test as a Predictor of High-Grade Prostate Cancer on Biopsy” as a Late-Breaking Abstract for presentation in Plenary I on Sunday May 18, 2014 at the AUA Annual meeting in Orlando, FL.

The data accepted are from a prospective, blinded study conducted at 26 urology clinics across the United States from October 2013 to January 2014. The data confirm the accuracy of the 4KscoreTMalgorithm in a United States population of men referred for prostate biopsy. The 4KscoreTM algorithm, which is based on the values of four different kallikrein blood tests (total PSA, free PSA, intact PSA and hK2) plus age, DRE and prior biopsy status, was originally studied in multiple European cohorts involving over 10,000 patients.

“These are challenging times in urology as we are seeing a decline in men screened for prostate cancer with PSA, yet we know that mortality from prostate cancer has steadily declined since the introduction of PSA screening,” said Dr. Stephen M. Zappala, MD FACS of Andover Urology. “The 4KscoreTM test offers new information on the probability of having a Gleason Score ≥ 7 cancer prior to undergoing a prostate biopsy. This is important, because we know that besides the potential side effects of biopsy such as bleeding and infection, up to 80% of prostate biopsies will either be negative for prostate cancer or will indicate a low grade disease that may be better monitored than treated. The 4KscoreTM test will offer both the Urologist and patient new information for the shared decision-making discussion about whether or not to have a prostate biopsy.”

“Acceptance as a late-breaking abstract highlights both the quality of the clinical data for the 4KscoreTM test and the urgent need to have a solution for more effective biomarker-based tests for managing prostate cancer risk and the disease itself,” said David Okrongly, President of OPKO Diagnostics. “We are looking forward to presenting the full US clinical trial data at the AUA meeting in May.”

“The results of the US clinical study are now complete and we are pleased to also announce that we are on track for launch of the 4Kscore Test on March 31, 2014,” said Phillip Frost, M.D., OPKO’s Chairman and Chief Executive Officer.

About the 4Kscore™ Test

The 4Kscore™ is a convenient blood test that measures the serum levels of four different prostate-derived kallikrein proteins: total PSA, free PSA, intact PSA and hK2. Levels of these biomarkers are combined with a patient’s age and digital rectal exam (DRE) status using a proprietary algorithm to calculate the probability of a finding of aggressive prostate cancer. The 4Kscore™ test is based on over a decade of research of the four kallikrein panel of biomarkers conducted by scientists at Memorial Sloan Kettering Cancer Center and leading research centers in Europe on over 10,000 patients. The information provided by the 4Kscore™ test can help facilitate the shared decision-making process between urologist and patient in determining the advisability of a prostate biopsy.

About Prostate Cancer

In 2013, over 238,000 new cases of prostate cancer will be identified and 29,720 men will die from the disease, according to estimates released by the National Cancer Institute, making it the second most deadly cancer in U.S. men. Prostate cancer is usually first detected by elevations in serum PSA. However, PSA level is often high for reasons unrelated to prostate cancer and, since an elevated PSA level often leads to biopsy, 75% of all prostate biopsies performed are either negative or indicate a low likelihood of aggressive cancer.

ABOUT OPKO HEALTH, INC.

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies. For more information, visit http://www.opko.com.

Being Right About The Market does Not Win you Friends Or Influence

Yesterday I advised readers to just WATCH  do not buy Quicksilver Resources ( KWK) .

The stock closed at $ 2.63

- despite the cold weather

- despite the draw down in nat gas

- despite a huge short position that at some point has to be brought onside

Note : I sold the Jack A. Bass positions out at the $ 3.50 in DEC/ Jan area when these catalysts did nothing for the stock.

The email response is ” just wait – it will rocket “.

That may well be at some time in the future BUT your money has to be at work each day and the trend in KWK is still down – along with a commodity price that will retreat with warmer weather.

to quote the noted investor Bob Dylan ” you don’t need a weatherman to tell which way the wind is blowin “

But you’d do well to have Jack Bass managing your account.

 

email info@jackbassteam.com

OR CALL JACK DIRECT AT 604-858-3202  – NO COST OR OBLIGATION –  same time zone as Los Angeles

Website http;//www.jackbassteam.com

 

aQuicksilver Resources Inc(KWK:NYSE, US)

BuySell

 

2.40USDDecrease0.23(-8.75%)Volume: 
Below Average
As of 24 Mar 2014 at 12:57 PM EDT.

 


Quote Details

Open 2.65 P/E Ratio (TTM) 2.9x
Last Bid/Size 2.40 / 184 EPS (TTM) 0.92
Last Ask/Size 2.41 / 91 Next Earnings 5 May 2014
Previous Close 2.63 Beta 2.02
Volume 2,262,661 Last Dividend
Average Volume 5,084,322 Dividend Yield 0.00%
Day High 2.66 Ex-Dividend Date
Day Low 2.39 Shares Outstanding 177.2M
52 Week High 3.67 # of Floating Shares 123.9008M
52 Week Low 1.44 Short Interest as % of Float 25.72%

 

 

 

 

 

Trading Alert : Insider Buying and Soros pushing OPK Higher

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

The overall trend of CEOs is illustrated in the chart below:

Opko Health Inc. (OPK): CEO and Chairman, 10% Owner Phillip Frost Md Et Al Bought 210,900 Shares

CEO & Chairman, 10% Owner of Opko Health Inc. (OPK) Phillip Frost Md Et Al bought 210,900 shares during the past week at an average price of $8.58. Opko Health Inc. was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. Opko Health Inc. has a market cap of $3.5 billion; its shares were traded at around $8.58 with and P/S ratio of 30.30.

Opko Health recently reported its third quarter 2013 financial results. Net loss for the three months ended Sept. 30, 2013, was $60.0 million, compared to a net loss of $10.2 million for the 2012 period. The increase in net loss for the three months ended Sept. 30, 2013, was primarily related to increased operating and clinical trial activities.

George Soros bought 745,000 shares in the quarter that ended on 09/30/2013, which is 0.072% of the $9.14 billion portfolio of Soros Fund Management LLC. Mario Gabelli owns 15,000 shares as of 09/30/2013, which accounts for 0.0008% of the $17.03 billion portfolio of GAMCO InvestorsOPKO Health Inc(OPK:NYSE, US)

Buy
9.95USDIncrease0.29(3.00%)Volume:
Above Average
As of 17 Mar 2014 at 10:45 AM EDT.

Quote Details

Open 9.77 P/E Ratio (TTM)
Last Bid/Size 9.95 / 76 EPS (TTM) -0.29
Last Ask/Size 9.96 / 19 Next Earnings 5 May 2014
Previous Close 9.66 Beta 1.05
Volume 1,457,907 Last Dividend
Average Volume 2,648,522 Dividend Yield 0.00%
Day High 10.15 Ex-Dividend Date
Day Low 9.76 Shares Outstanding 412.9M
52 Week High 12.95 # of Floating Shares 221.0759M
52 Week Low 6.14 Short Interest as % of Float 20.64%
chart

OPK, ROX, LTS , Dr. Phillip Frost Update

Castle Brand holders cheer the Frost Upsurge

We track three major positions for Jack A. Bass Managed Accounts and after the ROX haircut we are happy to see our profits regrowing at a faster trading volume pact this morning.

OPKO Health – we are looking for a short term $ 10 handle then on to the 52 week high $ 12.50 as the shorts are forced to cover. After that  milestone$ 18

LTS just released qrt. numbers indicate solid growth.

Isn’t it time you were a client of Jack A. Bass Managed Accounts

email info@jackbassteam.com or call  Jack direct at 604-858-3202 ( same time zone as Los Angeles) No cost or obligation for that introduction.

Castle Brands Inc(ROX:NYSE MKT LLC, US)

Buy
1.27USDIncrease0.11(9.48%)Volume:
Below Average
As of 14 Mar 2014 at 10:17 AM EDT.

 

Open 1.18 P/E Ratio (TTM)
Last Bid/Size 1.25 / 2 EPS (TTM) -0.11
Last Ask/Size 1.27 / 33 Next Earnings
Previous Close 1.16 Beta 0.87
Volume 193,450 Last Dividend
Average Volume 2,298,722 Dividend Yield 0.00%
Day High 1.27 Ex-Dividend Date
Day Low 1.15 Shares Outstanding 123.2M
52 Week High 1.55 # of Floating Shares 64.10851M
52 Week Low 0.2652 Short Interest as % of Float 0.56%

OPKO Health Inc(OPK:NYSE, US)

Buy
9.72USDIncrease0.395(4.24%)Volume:
Above Average
As of 14 Mar 2014 at 10:22 AM EDT.

 

Open 9.61 P/E Ratio (TTM)
Last Bid/Size 9.71 / 14 EPS (TTM) -0.29
Last Ask/Size 9.72 / 19 Next Earnings 5 May 2014
Previous Close 9.32 Beta 1.06
Volume 983,689 Last Dividend
Average Volume 2,545,999 Dividend Yield 0.00%
Day High 9.74 Ex-Dividend Date
Day Low 9.52 Shares Outstanding 412.9M
52 Week High 12.95 # of Floating Shares 221.116M
52 Week Low 6.14 Short Interest as % of Float 20.64%

Ladenburg Thalmann Financial Services Inc(LTS:NYSE MKT LLC, US)

BuySell
2.98USDIncrease0.14(4.93%)Volume:
Above Average
As of 14 Mar 2014 at 10:23 AM EDT.

 

Quote Details
Open 2.82 P/E Ratio (TTM)
Last Bid/Size 2.97 / 30 EPS (TTM) -0.05
Last Ask/Size 2.99 / 3 Next Earnings
Previous Close 2.84 Beta 1.10
Volume 92,016 Last Dividend
Average Volume 313,228 Dividend Yield 0.00%
Day High 2.99 Ex-Dividend Date
Day Low 2.82 Shares Outstanding 181.4M
52 Week High 3.54 # of Floating Shares 100.15M
52 Week Low 1.36 Short Interest as % of Float 2.30%
Follow

Get every new post delivered to your Inbox.

Join 1,937 other followers